Shah Gautam 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Sep 12, 2012
Insider Transaction Report
Form 4
Shah Gautam
SVP and Chief Compliance Ofc.
Transactions
- Exercise/Conversion
Common Stock
2012-09-12$1.60/sh+3,875$6,200→ 7,000 total - Exercise/Conversion
Common Stock
2012-09-12$4.00/sh+5,125$20,500→ 14,375 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-09-12−2,250→ 0 totalExercise: $1.60Exp: 2012-09-12→ Common Stock (2,250 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-09-12−5,125→ 0 totalExercise: $4.00Exp: 2012-09-12→ Common Stock (5,125 underlying) - Exercise/Conversion
Common Stock
2012-09-12$1.60/sh+2,250$3,600→ 9,250 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-09-12−3,875→ 0 totalExercise: $1.60Exp: 2012-09-12→ Common Stock (3,875 underlying) - Sale
Common Stock
2012-09-12$8.00/sh−11,250$90,000→ 3,125 total
Footnotes (3)
- [F1]This option was granted on May 26, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- [F2]This option was granted on December 16, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- [F3]This option was granted on December 20, 2005 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.